STAT3-induced long noncoding RNA LINC00668 promotes migration and invasion of non-small cell lung cancer via the miR-193a/KLF7 axis

被引:43
作者
An, Yun-xia [1 ]
Shang, Yi-jun [1 ]
Xu, Zhi-wei [1 ]
Zhang, Qun-cheng [1 ]
Wang, Zheng [1 ]
Xuan, Wei-xia [1 ]
Zhang, Xiao-ju [1 ]
机构
[1] Henan Prov Peoples Hosp, Dept Resp & Crit Care Med, 7 Weiwu Rd, Zhengzhou 450003, Henan, Peoples R China
关键词
LncRNA LINC00668; Non-small cell lung cancer; Prognosis; STAT3; miR-193a; KLF7; TARGETED THERAPY; METASTASIS; CERNA;
D O I
10.1016/j.biopha.2019.109023
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
100103 [病原生物学]; 100218 [急诊医学];
摘要
Long noncoding RNAs (lncRNAs) have been demonstrated to play significant roles in non-small cell lung cancer (NSCLC) progression. Recently, a newly identified lncRNA, LncRNA LINC00668 (LINC00668), was reported to be involved in the regulation of progression of several tumors. However, the expression pattern and biological function of LINC00668 in NSCLC remains largely unclear. In this study, we found that LINC00668 expression was significantly up-regulated in both NSCLC tissues and cell lines. we also showed that LINC00668 upregulation was induced by transcription factor STAT3. Clinical investigation demonstrated that high expression level of LINC00668 was associated with advanced TNM stage, histological grade and lymph node metastasis. Moreover, multivariate analysis confirmed LINC00668 expression level to be an independent prognostic indicator for overall survival of NSCLC patients. Functional assays indicated that knockdown of LINC00668 suppressed NSCLC cells proliferation, migration and invasion, and promoted apoptosis. Mechanistic studies indicated that LINC00668 is a direct target of miR-193a, leading to down-regulation in the expression of its target gene KLF7. Our findings suggested that STAT3-induced LINC00668 contributed to NSCLC progression through upregulating KLF7 expression by sponging miR-193a, and may serve as a prognostic biomarker and a potential target for NSCLC.
引用
收藏
页数:11
相关论文
共 34 条
[1]
[Anonymous], 2018, ONCOL RES
[2]
Long Noncoding RNAs as Biomarkers in Cancer [J].
Bolha, Luka ;
Ravnik-Glavac, Metka ;
Glavac, Damjan .
DISEASE MARKERS, 2017, 2017
[3]
Long Noncoding RNAs From Clinical Genetics to Therapeutic Targets? [J].
Boon, Reinier A. ;
Jae, Nicolas ;
Holdt, Lesca ;
Dimmeler, Stefanie .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (10) :1214-1226
[4]
KLF7 overexpression in human oral squamous cell carcinoma promotes migration and epithelial-mesenchymal transition [J].
Ding, Xiaojun ;
Wang, Xinhao ;
Gong, Yiming ;
Ruan, Hong ;
Sun, Yang ;
Yu, Youcheng .
ONCOLOGY LETTERS, 2017, 13 (04) :2281-2289
[5]
RETRACTED: SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88 (Retracted article. See vol. 42, 2023) [J].
Dong, Huaying ;
Wang, Wei ;
Mo, Shaowei ;
Chen, Ru ;
Zou, Kejian ;
Han, Jing ;
Zhang, Fan ;
Hu, Jianguo .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37
[6]
MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS [J].
Fan, Qian ;
Hu, Xiuting ;
Zhang, Haiyang ;
Wang, Shengguang ;
Zhang, Huilai ;
You, Chaoying ;
Zhang, Chen-Yu ;
Liang, Hongwei ;
Chen, Xi ;
Ba, Yi .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 44 (04) :1311-1324
[7]
Revealing protein-lncRNA interaction [J].
Ferre, Fabrizio ;
Colantoni, Alessio ;
Helmer-Citterich, Manuela .
BRIEFINGS IN BIOINFORMATICS, 2016, 17 (01) :106-116
[8]
Review: Regulation of the cancer epigenome by long non-coding RNAs [J].
Forrest, Megan E. ;
Khalil, Ahmad M. .
CANCER LETTERS, 2017, 407 :106-112
[9]
Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets [J].
Gupta, Subash Chandra ;
Tripathi, Yashoda Nandan .
INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (09) :1955-1967
[10]
Lung cancer: current therapies and new targeted treatments [J].
Hirsch, Fred R. ;
Scagliotti, Giorgio V. ;
Mulshine, James L. ;
Kwon, Regina ;
Curran, Walter J. ;
Wu, Yi-Long ;
Paz-Ares, Luis .
LANCET, 2017, 389 (10066) :299-311